Threefold approach to improving anticancer drug
24 October, 2019Biomedical engineers brought together tools from genome engineering, protein engineering and biomaterials science to improve the efficacy, accuracy and longevity of certain cancer therapies.
Light-activated catalyst destroys cancer cells' energy source
11 October, 2019Scientists have developed a compound of the metal iridium that will kill cancer cells in culture even when oxygen concentration is low.
Thermostable vaccine can be stored at warm temperatures
10 October, 2019The vaccine candidate has been engineered using a synthetic protein scaffold that could revolutionise the way vaccines are designed, produced and stored.
Psoriasis drug could treat rare bone cancer
26 September, 2019Researchers have discovered that the inflammatory molecule IL23, investigated for a number of autoimmune diseases, is critical to osteosarcoma formation and progression.
Arthritis drug provides relief for blood cancer patients
20 September, 2019A simple arthritis drug could be an effective, low-cost solution to treat patients with blood cancers such as polycythemia vera (PV) and essential thrombocythemia (ET).
Aus bioscience company acquires anticancer drug platform
19 September, 2019The iQ Group Global has announced its acquisition of a novel anticancer drug platform, known as TEX Core, from the University of Texas.
CELLINK BIO X6 bioprinting platform
10 September, 2019CELLINK has announced the BIO X6 — a six-printhead bioprinting platform that enables users to combine several materials, cells and tools.
Drug transporters bring cancer medication to its destination
02 September, 2019Researchers have transformed proteins and antibodies into stable, highly functional drug transporters with which tumour cells can be detected and killed.
Neural implant controlled by a smartphone
23 August, 2019Using Lego-like replaceable drug cartridges and Bluetooth Low Energy, the device can target specific neurons of interest using drugs and light for prolonged periods.
SA set to lift ban on GM crops
22 August, 2019Farmers on mainland South Australia will be given the choice to plant genetically modified (GM) food crops next season.
Anticancer compound derived from flowers
15 August, 2019Researchers have produced a compound with anticancer properties directly from the flowering garden plant known as feverfew, which is grown in many UK gardens.
CSL moving to Melbourne Biomedical Precinct
12 August, 2019Developer PDG will build laboratories and offices to house CSL's global corporate headquarters in the heart of the Melbourne Biomedical Precinct on Elizabeth St, Parkville.
Biologics Innovation Facility opens at UTS
07 August, 2019 by Lauren DavisThe University of Technology Sydney (UTS) has opened the doors of its new Biologics Innovation Facility — a training and production facility that seeks to enable new biotech discoveries as well as to drive the jobs of the future.
Cannabinoids could treat brain tumours
02 August, 2019MGC Pharmaceuticals has announced preclinical research highlighting the positive impact of using specific cannabinoid formulations in the treatment of glioblastoma.
Natural antibiotics best at combating resistance
30 July, 2019Natural antibiotics may be more effective than their synthetic counterparts at remaining effective in the wake of antibiotic resistance — although that doesn't mean they can't be given a helping hand.
